Identification of the first case of germline duplication of BRCA1 exon 13 in an Italian family
暂无分享,去创建一个
[1] A. Tchirkov,et al. Gene dosage methods as diagnostic tools for the identification of chromosome abnormalities. , 2008, Pathologie-biologie.
[2] W. Misdorp,et al. Tumors of the Mammary Gland , 2008 .
[3] A. Tutt,et al. Triple negative tumours: a critical review , 2007, Histopathology.
[4] A. Whittemore,et al. Screening for the BRCA1‐ins6kbEx13 mutation: potential for misdiagnosis , 2007, Human mutation.
[5] J. Benítez,et al. Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations , 2006, Oncogene.
[6] J. Reis-Filho,et al. Basal-like breast cancer and the BRCA1 phenotype , 2006, Oncogene.
[7] M. Federico,et al. Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations , 2006, Genes, chromosomes & cancer.
[8] J. Benítez,et al. Histopathology of BRCA1- and BRCA2-associated breast cancer. , 2006, Critical reviews in oncology/hematology.
[9] B. Ward,et al. Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families , 2005, Genes, chromosomes & cancer.
[10] S. Mazoyer. Genomic rearrangements in the BRCA1 and BRCA2 genes , 2005, Human mutation.
[11] J. Cigudosa,et al. Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers , 2005, Breast Cancer Research and Treatment.
[12] Ram Datar,et al. DNA extraction from archival formalin-fixed, paraffin-embedded tissues: heat-induced retrieval in alkaline solution , 2004, Histochemistry and Cell Biology.
[13] L. Bégin,et al. The Prognostic Implication of the Basal-Like (Cyclin Ehigh/p27low/p53+/Glomeruloid-Microvascular-Proliferation+) Phenotype of BRCA1-Related Breast Cancer , 2004, Cancer Research.
[14] L. Bégin,et al. Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer , 2003, British Journal of Cancer.
[15] G. Pelosi,et al. Microallelotyping Defines the Monoclonal or the Polyclonal Origin of Mixed and Collision Endocrine-Exocrine Tumors of the Gut , 2003, Laboratory Investigation.
[16] S. Narod,et al. BRCA mutations in Italian breast/ovarian cancer families , 2002, European Journal of Human Genetics.
[17] R. Start. AFIP Atlas of Tumor Pathology , 2000 .
[18] M. Beckmann,et al. The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group. , 2000, American journal of human genetics.
[19] S. Libutti,et al. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. , 1998, The American journal of pathology.
[20] L. Hood,et al. Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. , 1996, Genome research.
[21] D. Stoppa-Lyonnet,et al. An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation? , 1999, American journal of human genetics.